Pharmacy

The following drug, medical device recalls have occurred in the last month:

AstraZeneca saw sales rise 4 percent, to $21 billion, in fiscal year 2018, marking its strongest growth since 2009, according to The Wall Street Journal.

Using the Netflix-style payment model for purchasing hepatitis C drugs is expected to lower patient costs in Australia by 85 percent, according to a new study published in the New England Journal of Medicine, cited by STAT.

The three big insulin makers, Novo Nordisk, Eli Lilly and Sanofi, must face a lawsuit that claims they gouged diabetes patients with the price of their lifesaving medications, according to Bloomberg.

When drug prices rise and reimbursement rates remain stagnant, hospitals that purchase large quantities of pharmaceuticals find themselves in a financially vulnerable position.

23andMe, known for its at-home DNA testing kits, is working on creating its own drugs for a range of ailments, including skin treatments to heart disease, according to Business Insider.

Johnson & Johnson recently partnered with Apple on a study to test whether the Apple Watch can better detect and diagnose heart irregularities.

CAR-T therapies have emerged as promising new cancer treatments with shockingly high price tags. However, under a new proposal released by CMS Feb. 15, Medicare would pay for the therapies for patients across the nation.

As more countries work to reign in their healthcare spending, the Italian government is asking the decision-making body of the World Health Organization to set standards that drugmakers must meet for pricing transparency, according to STAT.

Here are 10 hospitals and health systems that posted job listings seeking pharmacy leadership talent in the last week.